Obesity and type 2 diabetes are deeply intertwined conditions, and weight loss remains one of the most powerful therapeutic tools for managing the disease. However, sustaining weight loss long-term remains a major challenge, and many people struggle due to biological and environmental factors.
About the Study
Novatrials is seeking adult volunteers, living with obesity and type 2 diabetes, to join a clinical study of a potential new weight loss treatment. The study drug will be administered by a small injection under the skin.
Eligibility Requirements
You may be suitable to join this study if you:
- Are aged 18 to 65 years and a non-smoker
- Have a BMI between 30 and 50, with weight not exceeding 159kgs
- Have been diagnosed with type 2 diabetes for at least 6 months and on a stable diabetes medication regimen for at least 3 months
- Have been unsuccessful in losing weight with diet and exercise
- Have not used any other weight loss drugs for at least 3 months
- Have not undergone surgery or device-based therapy for obesity
- Have not had a significant cardiovascular event such as a heart attack or stroke
- Are not pregnant, breastfeeding or trying to conceive
You can calculate your BMI here.
What to Expect
Participants will undergo:
- Screening period: up to 35 days with one in-clinic day visit
- Treatment period: up to 365 days, with between 12 to 17 in-clinic day visits. Select participants may be assigned to a cohort that includes two separate overnight in-clinic stays.
- Post-treatment follow-up period: up to four months with two in-clinic day visits
Further Information
All trial-related care and medication is provided at no cost by our dedicated healthcare team. Time and travel reimbursement is provided for all study visits at our clinic, located at Suite 301, 99 Pacific Highway Charlestown NSW 2290.
